Halozyme Therapeutics Inc (NAS:HALO)
$ 48.13 0.1 (0.21%) Market Cap: 6.11 Bil Enterprise Value: 6.89 Bil PE Ratio: 15.90 PB Ratio: 13.49 GF Score: 87/100

Halozyme Therapeutics Inc (HALO) Transcripts

  • 1